Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
matuzumab | epidermal growth factor receptor | biotech | Successful target | TTD , drugbank , DGIDB | Malignant neoplasm of stomach[MeSHID:D013274] Colorectal Cancer[MeSHID:D015179] Malignant neoplasm of lung[MeSHID:D008175] cervical cancer[MeSHID:D002583] Adenocarcinoma[MeSHID:D000230] Stomach[MeSHID:D013270] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.72 | investigational,phase 2 | unknown |
matuzumab | epidermal growth factor receptor | biotech | Successful target | TTD , drugbank , DGIDB | Malignant neoplasm of stomach[MeSHID:D013274] Colorectal Cancer[MeSHID:D015179] Malignant neoplasm of lung[MeSHID:D008175] cervical cancer[MeSHID:D002583] Adenocarcinoma[MeSHID:D000230] Stomach[MeSHID:D013270] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.72 | investigational,phase 2 | inhibitor |
click here to return to the previous page |